0001127602-22-022540.txt : 20220916 0001127602-22-022540.hdr.sgml : 20220916 20220916160308 ACCESSION NUMBER: 0001127602-22-022540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220915 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Machiels Alec CENTRAL INDEX KEY: 0001496687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 221248092 MAIL ADDRESS: STREET 1: 505 PARK AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-09-15 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001496687 Machiels Alec C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Common Stock 2022-09-15 4 M 0 1250 2.67 A 265024 D Common Stock 2022-09-15 4 S 0 1250 66.00 D 263774 D Common Stock 250000 I Indirect Owner (Bauhaus 1 LLC) Common Stock 11950 I Indirect Owner (Owned by Spouse) Common Stock 150000 I Indirect Owner (Spouse Trust) Stock Option (Right to Buy) 2.67 2022-09-15 4 M 0 1250 0 D 2023-12-04 Common Stock 1250 117279 D This is a scheduled exercise and sale from 10B5-1 trading plan. Owned by spouse. This option was granted on December 5, 2013 and fully vested. /s/ David Watson, attorney-in-fact for Alec Machiels 2022-09-16